Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
Pathway Name | Organism |
---|---|
E.coli O5ab | Escherichia coli |
E.coli O5ac | Escherichia coli |
E.coli O61 | Escherichia coli |
E.coli O65 | Escherichia coli |
E.coli O6H10K54 | Escherichia coli |
E.coli O6H16K15 | Escherichia coli |
E.coli O70 | Escherichia coli |
E.coli O71 | Escherichia coli |
E.coli O73ab | Escherichia coli |
E.coli O86 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
32081641 | Deficiency of O-linked-glycosylation regulates activation of T cells and aggravates Concanavalin A-induced liver injury | Hao X | 2020 Mar 30 |
|
32096313 | Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participants | Deng Y | 2020 Mar 18 |
|
32170309 | Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc–siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5′-exonuclease | Kumar P | 2020 Mar 14 |
|
31994716 | Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria | Agarwal S | 2020 Mar 07 |
|
32134930 | Reduced expression of a rhomboid protease, EhROM1, correlates with changes in the submembrane distribution and size of the Gal/GalNAc lectin subunits in the human protozoan parasite, Entamoeba histolytica | Welter BH | 2020 Mar 05 |
|
32062176 | Cellular uptake of N-acetyl-d-galactosamine-, N-acetyl-d-glucosamine- and d-mannose-containing fluorescent glycoconjugates investigated by liver intravital microscopy | Maklakova SY | 2020 Mar |
|
32561705 | Therapeutic siRNA: state of the art | Hu B | 2020 Jun 19 |
|
32521132 | Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria | Balwani M | 2020 Jun 11 |
|
32521139 | Givosiran — Running RNA Interference to Fight Porphyria Attacks | Gonzalez-Aseguinolaza G | 2020 Jun 11 |
|
32145269 | Different kinetics for the hepatic uptake of lipid nanoparticles between the apolipoprotein E/low density lipoprotein receptor and the N-acetyl-d-galactosamine/asialoglycoprotein receptor pathway | Sato Y | 2020 Jun 10 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates. |
|
J Am Chem Soc | 2009 Jul 22 | 19552408 |
Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression. |
|
Glycobiology | 1994 Jun | 7949653 |
Localization of O-glycan initiation, sphingomyelin synthesis, and glucosylceramide synthesis in Vero cells with respect to the endoplasmic reticulum-Golgi intermediate compartment. |
|
J Biol Chem | 1994 Feb 11 | 8307959 |
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells. |
|
Glycobiology | 1994 Aug | 7827404 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025